Our previous study demonstrated that apelin level increased significantly after the treatment of intracoronary implantation of bone marrow mononuclear cells (BMMCs), followed by the improvement of cardiac function in patients with severe ischemic heart failure. The present studies both in vivo and in vitro explored whether mesenchymal stem cells derived from bone marrow (BMSCs) activate the apelin-APJ pathway when differentiating into cardiomyogenic cells. Isolated BMSCs from rat femurs and tibias were cultured and expanded for three passages, labeled with DAPI, and treated with 5-azacytidine (5-AZ). BMSCs labeled with ad-EGFP were injected intramyocardially into the peri-infarct area of rat models with acute myocardial infarction. Immunofluorescence staining exposed that CMGs expressed apelin together with myogenic-specific proteins such as α-actin, troponin T, GATA-4, and connexin-43 at 7 days after 5-AZ treatment or EGFP-BMSC injection. RT-PCR revealed that mRNA in CMGs started to express apelin and APJ from day 7 and progressively increased until day 28. Cardiac function, as measured by echocardiography in vivo, was significantly improved in parallel with the extent of apelin expression after BMSC transplantation. Our finding indicated that the expression of the apelin-APJ pathway during differentiation of BMSCs into CMGs may be an important mechanism in regulation of myocardial regeneration and functional recovery after BMSC transplantation.
INTRODUCTION
. However, the mechanisms of their cellular reparative capacity have not yet been determined (1, 6, 11, 21, 28) . Our previous study (8) revealed that intracoronary Despite various therapeutic approaches that have been developed, ischemia heart disease is still a leading infusion of bone marrow-derived mononuclear cells (BMMCs) in patients with refractory chronic heart fail-cause of death throughout the world. As necrotic cardiomyocytes are replaced inevitably by fibrous tissues after ure secondary to ischemic cardiomyopathy significantly increased urine output and improved symptoms of heart myocardial infarction, dysfunctional myocardial remodeling is a fatal common outcome (29). Therefore, cell-failure within 72 h after treatment. However, this early remarkable effect cannot be readily attributed to myo-based therapies for cardiac regeneration are inducing great excitement. Recent studies indicate that bone mar-cardial regeneration from the donor cells. Thus, we hypothesized that infused cells might stimulate or release row stem cells harbor a multilineage differentiation potential and are able to differentiate into smooth muscle, soluble biological factors by paracrine mechanisms that account for their contributions to cardiac tissue repair endothelial, and cardiac cell phenotypes, and contribute to improvement of cardiac function in diseased myocar-and functional recovery (8) . Current studies from several investigators suggest dium (10, 16, 22, 23, 25) . More recently, some randomized clinical trials have also suggested that intramyocardial that bone marrow-derived mesenchymal stem cells (BMSCs) secrete a wide array of cytokines that exert or intracoronary delivery of autologous bone marrowderived cells improve regional perfusion and cardiac their protective benefits on surrounding tissue and stimulate vasculogenesis (4, 30) . However, there is a lack of function in patients with myocardial infarction (1,6,11, sufficient evidence to confirm that BMSCs are capable syringe filled with culture medium composed of lowglucose Dulbecco's modified Eagle's medium (DMEM, of secreting active cardiovascular peptides and thereby protect against cardiac injury and modulate positive ino-Gibco BRL, USA) supplemented with 10% fetal bovine serum (FBS, Hangzhou Sijiqing Biological Engineering tropy (4, 30) .
Apelin, a newly discovered inotropic peptide, is the Materials Co. Ltd., China). Mononuclear cells were collected at the Percoll interface, rinsed twice in low-glucose endogenous ligand for the orphaned G protein-coupled receptor (APJ) (31, 32) . The apelin-APJ signaling path-DMEM, and plated at a density of 2 × 10 5 /cm 2 in lowglucose DMEM and incubated at 37°C in a humidified way is widely represented in the heart and vasculature, and is emerging as an important regulator of cardiovas-atmosphere of 95% air 5% CO 2 . Nonadherent cells were removed after 24 h and culture media were replaced ev-cular homeostasis (13, 14, 20) . In preclinical models, apelin-APJ signaling also attenuates ischemic myocar-ery 2 or 3 days. When these primary BMSCs reached 90% confluence, they were trypsinized (trypsin-0.02% dial injury and maintains cardiac performance in infarction and chronic pressure overload (2, 3, 17) . The plasma EDTA, Hyclone, China), counted, and passaged at a density of 6 × 10 5 /cm 2 and the cells of passage 3 were levels of apelin significantly decrease in patients with heart failure (7) . Moreover, recently the apelin-APJ used for study. These cells were trypsinized and counted after they were rinsed in PBS (pH 7.2). Aliquots of 2 × pathway has been identified as an important regulator of myocardial cell specification and heart development. 10 5 cells were incubated for 30 min with phycoerythrin (PE)/fluorescein (FITC)-labeled monoclonal antibodies Zebrafish developmental models show that ectopic expression of apelin and APJ result in the complete ab-against rat CD44, CD90, CD105, CD73, CD45, and CD34 (Beijing Boisynthesis Biotechnology Co, BJ). sence of cardiomyocytes development. Apelin-APJ signaling has been proven to serve as a critical gradient for After a PBS wash, the stained cells were run on a flow cytometer (FACS Calibur, Becton-Dickinson, USA) to migration of mesodermal cells fated to contribute to the myocardial lineage, which plays a cell-autonomous role confirm BMSC purity. Before induction of differentiation or transplantation, in myocardial specification and the formation of myocardial progenitors (26, 35) .
BMSCs were labeled with 4′6-diamidino-2′-phenylindole (DAPI) in vitro. For transplantation in vivo, BMSCs Previously, our study found that apelin increased significantly after intracoronary implantation of BMMCs, were transduced with a retroviral vector encoding the enhanced green fluorescent protein (EGFP-BMSCs). followed by the improvement of cardiac function in patients with severe ischemic heart failure (9). We consid-Transduction efficiency was assessed by fluorescenceactivated cell sorting (FACS) analysis. ered that increased apelin levels may act as a paracrine mediator following BMMC therapy. Furthermore, we Cardiomyogenic (CMG) Cell Differentiation found that no one has reported whether stem cells impliof BMSCs In Vitro cate the expression of the apelin and APJ system in cardiomyogenic cells during the course of its differentia-
The differentiation of CMG cells from BMSCs was performed as previously described (25) . The third pas-tion.
In the present study, we designed experiments in both sage of rat BMSCs were seeded into 35-mm dishes at a density of 20,000 cells/cm 2 in DMEM medium contain-in vitro and in vivo models to explore: 1) whether the apelin-APJ pathway is expressed during BMSC differen-ing 10% FBS and 1% antibiotics (100 U/ml penicillin and 250 ng/ml streptomycin). On the second day, the tiation into cardiomyogenic cells, and 2) the potential connection between the expression of apelin-APJ signal-medium was changed, and the cells were exposed to the medium with 20% FBS or treated for 24 h with the me-ing and the improvement of heart function in acute myocardial infarction models. dium consisting of 20% FBS and 5-azacytidine (5-AZ; 3 µmol/L). Thereafter, the cells were cultured in medium MATERIALS AND METHODS consisting of 20% FBS and 1% antibiotics, and the me-BMSC Isolation, Culture, and Labeling dium was changed twice a week for 4 weeks until the experiment was terminated. Control cells were cultured The procedures were performed in accordance with the guidelines for animal experimentation of Navy Gen-in DMEM supplemented with 5% FBS and antibiotics. CMG cells showed spontaneous beating. eral Hospital Committee. Sprague-Dawley (SD) rats were sacrificed, and femurs and tibia were aseptically Myocardial Infarction Models and BMSC Injection harvested. The adherent muscles and soft tissues were removed. The proximal and distal ends of the bone were Ligation of the left anterior descending coronary artery (LAD) was performed in 6-week-old SD female excised just at the beginning of the marrow cavity. Following a rinse in phosphate-buffered saline (PBS), rats. Animals were anesthetized using a combination of xylazine (10 mg/kg) and ketamine (80 mg/kg) injected whole marrow plugs were obtained by flushing the bone marrow cavity with an 18-gauge needle connected to a intramuscularly and a left thoracotomy was performed under artificial ventilation with air. The heart was ac-Biotechnology CO, LTD, China, 1:100) as a control. CMG cells were also stained with a rabbit monoclonal cessed through the fourth intercostal space. The pericardial sac was cut and the heart exteriorized through the anti-apelin-12 antibody (1:200; Phoenix Pharmaceuticals, Belmont, CA, USA). Confocal images were ob-resulting space. The LAD was ligated with a 7-0 silk suture approximately midway between the left atrium tained using a 40× objective on a Leica Microsystems TCS SP laser scanning confocal microscope. Digitized and the apex of the heart. Successful performance of coronary occlusion was verified by observing the devel-confocal images were processed by Leica confocal software and Adobe Photoshop (version 6.0). opment of a pale color in the distal myocardium after ligation and by recording EKG evidence of infarction
The hearts of rats sacrificed at day 7, 14, and 28 were subject to histological analysis by hematoxylin-eosin (ST segment elevation >1 mm in leads V1-V6). In the sham animals the ligature was left loose. Before BMSC and immunohistochemical staining. Assessment of the cell grafting was performed as follows. The apical myo-transplantation, animals were randomized into three groups: (A) sham-operated animals with no injection cardium below the coronary artery ligation site was sectioned. Cryostat sections (10 mm) were cut from frozen performed; (B) control animals that received only PBS injection; (C) animals that received EGFP-BMSCs in-GFP-positive tissue samples; EGFP was detected and quantified with an anti-EGFP antibody (1:200; United jection. Accordingly, 1 h later a total of 1 × 10 6 third passage EGFP-BMSCs suspended in PBS or an equiva-States Biologica). Serial sections were immunolabeled with antibodies against sarcomeric α-actin, connexin-43, lent volume of PBS alone was injected at five different sites located in the infarct border zone. The investigators and GATA-4 and then were stained with a rabbit monoclonal anti-apelin-12 antibody followed by incubation responsible for surgery and cell injection were blinded to the treatment groups. All procedures were conducted with FITC-conjugated secondary antisera (Phoenix Pharmaceuticals, Belmont, CA, USA). The area of GFP-posi-in accordance with the Guide for the Care and Use of Laboratory Animals and the Animal Welfare Act in tive BMSCs in each tissue section was measured. Confocal images were obtained and processed as described China and approved by the Navy General Hospital Standing Committee.
above.
Apelin and APJ Gene Expression Immunofluorescence Staining
DAPI-positive CMG cells were stained with mouse To confirm messenger RNA (mRNA) expression of the apelin and APJ genes, reverse transcription PCR monoclonal antibodies against sarcomeric α-actin, troponin T (TnT), connexin-43, and GATA-4 at 1:200 dilu-(RT-PCR) was performed. Total RNA from the CMG cells (baseline and 3, 7, 14, 21, and 28 days after 5-tion (Beijing Boisynthesis Biotechnology Co, LTD) and FITC-conjugated secondary antibody (Beijing ZGB, AZ treatment) were prepared by the acid guanidinium thiocyanate-phenol-chloroform extraction method. One microgram of total RNA with a combination of oligo(dT) and random hexamer primers was subject to first-strand complementary DNA (cDNA) synthesis in a 20-µl reaction for 60 min at 37°C. After completion of the cDNA synthesis, 20 µl was used for each PCR reaction according to the manufacturer's instruction (Promega, USA). The primer sequences used for amplification of the rat apelin were 5′-TGCTCTGGCTCTCCTTGACT-3′ (sense strand) and 5′-ATGGGTCCCTTATGGGAGAG-3′ (antisense strand). The primer sequences used for amplification of rat APJ were 5′-CTGCTGAGCATCATCGT GGT-3′ (sense strand) and 5′-AGGGCCAGTGCAG CAAATT-3′ (antisense strand); The primer sequences used for amplification of internal control GAPDH were AGTATGACTC-CACTCACGGCAA (sense strand) and TCTCGCTCCTGGAAGATGGT (antisense strand).
The PCR products were separated on a 1% agarose gel, and the amplified cDNA bands were visualized by ethidium bromide staining. The bands imaged by Chemi-Genius Bio Imaging System were analyzed via Gene Tools software.
Echocardiography
Rat heart function was assessed by transthoracic echocardiography, which was performed at 1, 7, and 28 days after MI and cell transplantation, using 12-MHz transducer system designed for cardiac ultrasound (HP RESULTS Sonos 5500). Two-dimensional images were obtained at BMSC-Derived Cardiomyocytes Express Apelin midpapillary and apical levels. End-diastolic (EDV) and
and APJ In Vitro end-systolic (ESV) left ventricular volumes were obtained by biplane area length method. Percent left ven-BMSCs displayed a fibroblast-like morphology under phase-contrast microscopy and expressed CD44, CD90, tricular ejection fraction (LVEF) and the percent fractional shortening (FS) were calculated. All measurements CD105, and CD73, but did not express markers CD45 and CD34 and cardiac cell lineages before 5-AZ treat-were averaged on three consecutive cardiac cycles and were analyzed by two independent observers who were ment (Fig. 1) . DAPI staining was used to identify BMSCs (blue nucleus with multiple nucleoi) from dif-blinded to the treatment status of the animals. ferentiated myocytes. To confirm that BMSC-derived
Statistical Analysis
CMGs exhibited molecular characteristics of cardiac cells after 3, 7, 14, 21, and 28 days of 5-AZ treatment, All results are presented as mean ± SE. Data were analyzed by one-way or two-way ANOVA with re-we examined expression of several cardiac myocyte markers. These cells stained positive for the cardiac-peated measures followed by Bonferroni's post hoc test. Statistical significance was assumed at a value of p < specific transcription factor GATA-4, the cardiacspecific proteins sarcomeric α-actin, and TnT, and the 0.05. intercellular connection and electrical coupling factor one such cell type, bone marrow mononuclear cells (BMMCs), attenuated the progress of postinfarction ven-connexin-43 ( Fig. 2) . Apelin expression following 5-AZ treatment was also demonstrated with confocal laser tricular remodeling and improved left ventricular function. The utility of these cells was ascribed to their abil-scanning microscopy images. BMSC-derived CMGs coexpressed apelin with the cardiac sarcomeric α-actin, ity to differentiate into cell types with reparative capacity (12,18,19,27,34) . In our studies, we found that BMSC TnT, connexin-43, and the transcriptional factor GATA-4 at 7 days after 5-AZ treatment (Fig. 2) .
transplantation generated similar beneficial effects in injured myocardium, suggesting that engrafted BMSCs The induced expression of apelin after 5-AZ treatment was further confirmed by RT-PCR analysis.
can either differentiate into functional reparative cells or that they generate one or more factors that enhance Apelin expression was not detected in BMSCs before 5-AZ treatment but it was detected afterwards. The ex-regeneration and increase function. Our data favor the latter explanation. Thus, we found that the expression of pression level gradually increased in a time-dependent manner after 5-AZ treatment (Fig. 3A) . The expression apelin in cardiomyogenic cells, which were derived from BMSCs, was significantly increased and paralleled pattern of APJ paralleled apelin expression in BMSCs before and after 5-AZ treatment (Fig. 3B ). Quantitative the regeneration of cardiac cells in impaired cardiac tissue. These results suggest that apelin was involved in analyses of apelin expression and APJ were significantly higher in cells at 7, 14, 21, and 28 days in comparison the mechanisms underlying the tissue repair of ischemic myocardial infarct. to the untreated BMSC group.
APJ receptors have been found in developing heart CMG Cells Express Apelin In Vivo tubes and vasculature, and in adult cardiac endothelium, atria, and endocardium. The locations correlate with the We used enhanced green fluorescent protein (EGFP) as a marker to identify the engrafted cells in heart. Ani-expression patterns of apelin and those of cognate components of the cardiovascular system (13, 15, 31) . Although mals were sacrificed at days 7, 14, and 28 (n = 8 each) after the injection of male rat BMSCs-EGFP in the peri-recent investigations concluded that apelin and G protein-coupled receptor Agtrl1b participated in modulation infarct area of female rats. EGFP-positive cells were observed in the heart of the BMSC transplantation group.
of early development of myocardial progenitors (26, 35) , these data require confirmation. However, depletion of They were mostly localized in the border area. The frequency of EGFP-positive cardiomyocytes was very low the Agtrl1b receptor results in a reduced number of myocardial progenitor cells and the absence of an orga-in remote myocardium. Sarcomeric α-actin, TnT, GATA-4, and connexin-43 were used as markers for nized cardiac structure (26) . Our in vitro experiments in CMG cells showed that the expression of apelin was CMG cells, which were colocalized with apelin as shown in Figure 4 . No EGFP-positive cells were de-significantly increased. The levels of apelin and APJ mRNA expression progressively intensified between day tected in the PBS control group. 7 and 28 after 5-AZ treatment. Experiments performed Improvement of Cardiac Contract Function in vivo on the rat models with myocardial infarction Was Accompanied by Apelin Expression demonstrated that the appearance of CMG cells was correlated with the presence of EGFP and other myogenic-Eight rats in each group were examined for cardiac function by echocardiography at 1, 7, and 28 days after specific peptide markers, such as α-actin, TnT, GATA-4, and connexin-43 after EGFP-BMSCs were injected EGFP-BMSC engraftment. As shown in Table 1 , left ventricular ejection fraction (LVEF) and fractional short-into the infarct area of ischemic myocardium. These data indicate that BMSC transplantation is capable of en-ening (FS) progressively and significantly increased from 7 days to 28 days after BMSC transplantation (p < hancing the expression of apelin and APJ in the same situation. 0.05-0.01). Conversely, in the control group, LVEF and FS gradually decreased to 28 days (p < 0.01). However, Apelin has been reported to induce potent endogenous positive inotropic benefits and to reduce ventricular no significant changes were seen for end-diastolic volumes after BMSC transplantation.
preload and afterload through triggering nitric oxidedependent vasodilatation in normal and failing hearts DISCUSSION (3, 5, 33) . Ronkainen et al. found hypoxia inducible factor regulates the cardiac expression and secretion of apelin Different types of BMSCs have been proposed as potential sources of cell therapy for ischemic heart disease (24) . In our study, depressed cardiac function, as determined by LVEF and FS in the rat model of cardiac in-(22). BMSCs are regarded as multipotent stem cells and have been used experimentally as treatment for ischemic farction, was significantly improved, in parallel with the apelin expression in CMG cells. These findings concur heart disease in preclinical and clinical studies (1, 8, 11, 16, 21, 23, 25, 35) . Wollert and colleagues (21) and others with Szokodi et al., who reported that administration of apelin-16 produced a dose dependent increase in myo-(1,8,11) reported that intracoronary administration of Effect of intracoronary transplantation of autologous bone cardial contractility in isolated rat heart preparations marrow-derived mononuclear cells on outcomes of pa- (31) . Our study therefore suggests that in the process of tients with refractory chronic heart failure secondary to BMSC differentiation into CMG cells, activated apelin- 
